We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$726B
AUM Growth
+$72B
Cap. Flow
+$18.3B
Cap. Flow %
2.52%
Top 10 Hldgs %
22.02%
Holding
4,790
New
331
Increased
3,384
Reduced
720
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 23.98%
2 Financials 13.87%
3 Healthcare 13.39%
4 Consumer Discretionary 11.81%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCAP icon
4326
Crescent Capital BDC
CCAP
$403M
$210K ﹤0.01%
11,222
KEQU icon
4327
Kewaunee Scientific
KEQU
$102M
$210K ﹤0.01%
14,656
TEKK
4328
DELISTED
Tekkorp Digital Acquisition Corp. Class A Ordinary Shares
TEKK
$210K ﹤0.01%
21,539
+10,578
+97% +$104K
TRIN icon
4329
Trinity Capital Inc.
TRIN
$1.58B
$209K ﹤0.01%
14,443
XPL icon
4330
Solitario Resources
XPL
$68.3M
$209K ﹤0.01%
311,982
PCOM
4331
DELISTED
Points.com Inc. Common Shares
PCOM
$208K ﹤0.01%
12,126
VECT
4332
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$207K ﹤0.01%
+17,780
New +$270K
EAC
4333
DELISTED
Edify Acquisition Corp. Class A Common Stock
EAC
$206K ﹤0.01%
21,442
+5,786
+37% +$56.2K
AVCT
4334
DELISTED
American Virtual Cloud Technologies, Inc. Common Stock
AVCT
$206K ﹤0.01%
2,288
+1,156
+102% +$111K
LARK icon
4335
Landmark Bancorp
LARK
$191M
$205K ﹤0.01%
9,695
-30,558
-76% -$623K
PMGM
4336
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
$205K ﹤0.01%
21,074
+7,775
+58% +$75.9K
NVIV
4337
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$205K ﹤0.01%
11,045
+3,577
+48% +$68.1K
RNGR icon
4338
Ranger Energy Services
RNGR
$376M
$204K ﹤0.01%
25,555
SDOT icon
4339
Sadot Group
SDOT
$14M
$204K ﹤0.01%
73
-39
-35% -$118K
KAIR
4340
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
$203K ﹤0.01%
21,022
+8,577
+69% +$83.7K
AUTO
4341
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$203K ﹤0.01%
65,127
YI
4342
111 Inc
YI
$33.9M
$200K ﹤0.01%
2,207
+690
+45% +$72.5K
GMDA
4343
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$200K ﹤0.01%
31,257
ATXI
4344
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$199K ﹤0.01%
71
-47
-40% -$232K
TMBR
4345
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$199K ﹤0.01%
3,277
+2,696
+464% +$189K
TLSA icon
4346
Tiziana Life Sciences
TLSA
$131M
$198K ﹤0.01%
84,581
+69,729
+469% +$172K
PHIO icon
4347
Phio Pharmaceuticals
PHIO
$11.8M
$197K ﹤0.01%
810
HCDI
4348
DELISTED
Harbor Custom Development, Inc. Common Stock
HCDI
$197K ﹤0.01%
3,053
+1,426
+88% +$93.5K
CNSP icon
4349
CNS Pharmaceuticals
CNSP
$8.51M
0
KRNL
4350
DELISTED
Kernel Group Holdings, Inc. Class A Ordinary Shares
KRNL
$196K ﹤0.01%
+20,223
New +$197K

Similar funds

Geode Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
  • Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
  • Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
  • Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
  • Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
  • Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
  • Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.

Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.